News - Solaris

Alexion Sees Growth From Competition-Free Drug Cabot Wealth Advisory - Salem,MA,USA The FDA approved Solaris for the treatment of the blood disease paroxysmal nocturnal hemoglobinuria or PNH in March 2007, IBD reported. ...

---